Abdelrahman N. Emara

Abdelrahman N. Emara

Pharmaceutical Outcomes and Policy, University of Florida Collage of Pharmacy, Gainesville, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in European Journal of Pharmacology
Verified
Journal Article
Closed access
AEAbdelrahman N. Emara
Abdelrahman N. Emara
MWMoheb Wadie
Moheb Wadie
NMNoha Mansour
Noha Mansour
Mohamed E. E. ShamsMohamed E. E. Shams
Mohamed E. E. Shams

Verified
Journal Article
Open access
PDF file
AEAbdelrahman N. Emara
Abdelrahman N. Emara
NMNoha Mansour
Noha Mansour
Mohamed Hassan ElnaemMohamed Hassan Elnaem
Mohamed Hassan Elnaem
MWMoheb Wadie
Moheb Wadie
IDInderpal Singh Dehele
Inderpal Singh Dehele
Mohamed E. E. ShamsMohamed E. E. Shams
Mohamed E. E. Shams
Diuretic therapy is the mainstay during episodes of acute heart failure (AHF). Diuretic resistance is often encountered and poses a substantial challenge for clinicians. There is a lack of evidence on the optimal strategies to tackle this problem. This review aimed to compare the outcomes associated with congestion management based on a strategy of pharmacological nondiuretic-based regimens. The PubMed, Cochrane Library, Scopus, and ScienceDirect databases were systematically searched for all randomised controlled trials (RCTs) of adjuvant pharmacological treatments used during hospitalisation episodes of AHF patients. Congestion relief constitutes the main target in AHF; hence, only studies with efficacy indicators related to decongestion enhancement were included. The Cochrane risk-of-bias tool was used to evaluate the methodological quality of the included RCTs. Twenty-three studies were included; dyspnea relief constituted the critical efficacy endpoint in most included studies. However, substantial variations in dyspnea measurement were found. Tolvaptan and serelaxin were found to be promising options that might improve decongestion in AHF patients. However, further high-quality RCTs using a standardised approach to diuretic management, including dosing and monitoring strategies, are crucial to provide new insights and recommendations for managing heart failure in acute settings.